Stock Comparison

TEVA vs UTHR

Teva Pharma Industries Ltd ADR and United Therapeutics Corporation side by side — valuation, profitability, growth and risk.

TEVA

Teva Pharma Industries Ltd ADR

Healthcare

UTHR

United Therapeutics Corporation

Healthcare

Valuation

Market Cap

$41.60B

$21.87B

P/E (TTM)

59.5

18.3

Forward P/E

17.2

18.6

Price/Sales

2.4

6.9

Price/Book

5.4

3.4

EV/EBITDA

20.9

11.1

Dividend Yield

—

Profitability

Net Margin

9.02%

41.56%

Operating Margin

13.19%

44.49%

Return on Equity

9.69%

19.30%

Return on Assets

5.13%

11.60%

Growth (YoY)

Revenue Growth

-0.80%

-1.90%

Earnings Growth

72.20%

13.40%

Price & Risk

Beta

0.9

0.6

52-Week High

$36.74

$596.76

52-Week Low

$17.54

$304.76

Analyst Target

$41.20

$658.08

Compare TEVA and UTHR your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.